The 24th CPH successfully concluded from June 16 to 18, 2026, at the Shanghai New International Expo Center.The event brought together over 3,700 companies from around the world and attracted more than 110,000 professional visitors, marking a pivotal shift in the global pharmaceutical industry from a "scale race" to a new era defined by "technological density." As a representative of industry innovation, Pizhou Futong Biochemicals Co., Ltd. made a major debut at booth E4A62 with its flagship products, including ginkgo leaf extract. Leveraging its outstanding R&D capabilities and customized service solutions, the company became a focal point throughout the exhibition and established deep strategic cooperation agreements with numerous domestic and international clients.

At Futong Biochemicals' booth, professional visitors streamed in continuously, creating an unprecedentedly vibrant atmosphere for business discussions. The ginkgo leaf extract on display was undoubtedly the highlight of the exhibition, fully showcasing the company's strong capabilities in the field of natural herbal plant extracts. Leveraging its powerful brand influence and precise product positioning, Futong Biochemicals enjoyed a "harvest season" throughout the three-day event. During the exhibition, the company's sales and technical teams demonstrated their professionalism and efficiency by engaging in in-depth discussions with international clients from regions including the United States, Europe, the Americas, and Southeast Asia. Through comprehensive presentations on technical specifications, supply capacity, and compliance systems, Futong Biochemicals reached preliminary cooperation agreements with several well-known enterprises on-site, laying a solid foundation for future market expansion.

Richard pointed out: "Currently, with the recovery of global pharmaceutical investment and financing combined with strong momentum in innovative drugs, Futong Biochemicals has always been committed to providing customers with the highest quality products and services. We hope to achieve mutual value through continuous technological innovation and collaboration with partners across the supply chain."

Richard pointed out: "Currently, with the recovery of global pharmaceutical investment and financing combined with strong momentum in innovative drugs, Futong Biochemicals has always been committed to providing customers with the highest quality products and services. We hope to achieve mutual value through continuous technological innovation and collaboration with partners across the supply chain."

